SLC31A1 and breast cancer: Moreover, AUC was 0.854 (Fig. 8C), 0.746 (Fig. 8E), and 0.729 (Fig. 8G) in the corresponding chemotherapy regimens, revealing that SLC31A1 was able to distinguish non-response groups from response groups in breast cancer.